Favorable outcome of PML‐RARα short isoform and FLT3‐ITD mutation in a patient with several adverse prognostic markers: A case report

Key Clinical Message Complete molecular remission in a “variant APL” patient with short isoform of PML‐RARα and FLT3‐ITD mutation was achieved in response to ATRA and ATO plus IDA instead of standard treatment protocol. The use of FLT3 inhibitor in APL induction management is implicated to prevent d...

Full description

Bibliographic Details
Main Authors: Mohammed A. Bafail, Rahaf AlTahan, Manar A. Samman, Suha A. Tashkandi, Ibraheem H. Motabi, Abdul Ali Peer‐Zada
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.7637